Combining stem cell engineering and drug therapy to suppress abnormal bone formation
by Kyoto University edited by Lisa Lock, reviewed by Robert Egan Credit: JBMR Plus (2025). DOI: 10.1093/jbmrpl/ziaf068 A research team led by Associate Professor Makoto Ikeya in the Department of Clinical Application at Kyoto University has developed a promising new therapeutic strategy for fibrodysplasia ossificans progressiva (FOP)—a rare and severely disabling genetic disorder—by combining low-dose rapamycin with mesenchymal stem/stromal […]
Combining stem cell engineering and drug therapy to suppress abnormal bone formation Read More »
